Wealthspire Advisors (Maryland)’s Foundation Medicine, Inc. FMI Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-960	Closed	-$131K	–	2613
2018 Q2	$131K	Sell	960 -695	-42%	-$63.1K	0.01%	598
2018 Q1	$130K	Sell	1,655 -465	-22%	-$34.3K	0.01%	610
2017 Q4	$145K	Hold	2,120	–	–	0.01%	587
2017 Q3	$85K	Sell	2,120 -1,890	-47%	-$72.9K	0.01%	777
2017 Q2	$159K	Hold	4,010	–	–	0.02%	534
2017 Q1	$129K	Hold	4,010	–	–	0.02%	511
2016 Q4	$71K	Hold	4,010	–	–	0.01%	680
2016 Q3	$94K	Buy	+4,010	New	+$91K	0.01%	591

Wealthspire Advisors (Maryland)'s FMI Position: Q3 2018 in Review

Wealthspire Advisors (Maryland) sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 960 shares — an estimated $131K sold.

Wealthspire Advisors (Maryland) first reported a position in FMI in Q3 2016 and held it in 8 quarters. The position peaked at $159K in Q2 2017. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Wealthspire Advisors (Maryland) reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 960 Foundation Medicine, Inc. shares in Q3 2018, an estimated $131K.
Wealthspire Advisors (Maryland) first reported a position in Foundation Medicine, Inc. in Q3 2016 and held it in 8 quarters.
Wealthspire Advisors (Maryland)'s Foundation Medicine, Inc. position peaked at $159K in Q2 2017.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2018, filed 13 Nov 2018.